(Q45722599)

15 December 2017

title

Hepatitis A virus infection in hepatitis C Brazilian patients (English)

1 reference

15 December 2017

1 reference

1 reference

Devalle S

1

1 reference

15 December 2017

de Paula VS

2

1 reference

15 December 2017

de Oliveira JM

3

1 reference

15 December 2017

Niel C

4

1 reference

15 December 2017

Gaspar AM

5

1 reference

15 December 2017

publication date

1 August 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

47

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

125-128

1 reference

Hepatitis A shifting epidemiology in Latin America

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Hepatitis A in Latin America: a changing epidemiologic pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Risks associated with hepatitis A and hepatitis B in patients with hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Hepatitis C and the British Columbia experience with hepatitis A vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

A virological perspective on the need for vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Acute, hepatitis-A super-infection in HBV carriers, or chronic liver disease related to HBV or HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Prevalence of hepatitis C virus infection in patients hospitalized for hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Acute hepatitis A in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Differences in HCV antibody patterns in haemodialysis patients infected with the same virus isolate

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Characterization of hepatitis A virus isolates from subgenotypes IA and IB in Rio de Janeiro, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Duration of viremia in hepatitis A virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Duality of patterns in hepatitis A epidemiology: a study involving two socioeconomically distinct populations in Campinas, São Paulo State, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

Age-specific prevalence of antibodies to hepatitis A in children and adolescents from Rio de Janeiro, Brazil, 1978 and 1995. Relationship of prevalence to environmental factors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2803%2900061-6

7 January 2021

10.1016/S0163-4453(03)00061-6

Identifiers

DOI

1 reference

15 December 2017

1 reference